Derek DiRocco - 09 Nov 2022 Form 3 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
Director
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Issuer symbol
ACRV
Transactions as of
09 Nov 2022
Net transactions value
$0
Form type
3
Filing time
09 Nov 2022, 19:30:20 UTC
Previous filing
10 Jun 2022
Next filing
16 Nov 2022

No securities are beneficially owned.

Remarks:

No securities beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney